A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors
Clinical trial NCT02136069 · COMPLETED
Trial details
- NCT number
- NCT02136069
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-24
- Primary completion
- 2020-06-23
- Enrollment
- 397
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.